The Economic Impact of Care & Treatment of Diabetic Foot Ulcers at a Tertiary Government Hospital in the Philippines: A Retrospective Cohort Study
Dinkum Journal of Medical Innovations · 2024
DOI: 10.71017/djmi.3.07.d-0295 ↗Abstract
Diabetic foot ulcer is a micro vascular complication of diabetes mellitus that commonly results in in-hospital admission and requirement for surgery. Significant healthcare expenditure is thus required to achieve care for this population of longstanding patients this study sought to determine the direct medical costs of treating patients with diabetic foot ulcers in East Avenue Medical Center, a tertiary government hospital in the Philippines retrospective review of medical records and hospital bills Records and hospital bills of 124 patients admitted for diabetic foot ulcers from January to June 2023 was reviewed to determine the direct costs of care the overall cost of managing 124 patients with diabetic foot ulcers in a span of 6-months was 30,051,927.58 Php (537,601.57 USD) with a mean cost of 242,354.25 Php (4,335.50 USD) per patient. Laboratory diagnostics (31.33%), medications from the pharmacy (20.10%), and room and board (18.65%) contributed the largest proportions of cost. High cost was associated with prolonged admission and delay in surgical procedure. Factors leading to prolonged admission were optimization of patients to meet laboratory targets, peri-operative availability of blood products, and operating room allotment care for diabetic foot patients is costly and highly variable. Policies to fast-track care may focus on allotment of blood products for optimization and peri-operative use as well as operating room availability. This study was limited only to direct costs and in-hospital care of patients with diabetic foot ulcers. Indirect costs were difficult to elucidate due to its inherent subjectivity per patient.
EUVIMED